Oura delays $15BN US IPO

Oura Health, the wearable analytics company, has postponed its anticipated US initial public offering valued at around $15 billion. The postponement comes amid broader market volatility and heightened investor caution surrounding large-cap tech and consumer-tech listings. The article notes that while the company had signaled readiness for a public listing, external market conditions and pricing dynamics led to a strategic pause. No new listing window was provided, leaving the company and potential investors in a wait-and-see stance. The delay could impact strategic plans, including potential partnerships, equity-based compensation for employees, and the pace of global expansion. Market observers may reassess the IPO window in the coming quarters as conditions stabilize, though no definitive timeline is given. The development underscores the sensitivity of high-valuation tech IPOs to macroeconomic trends and investor appetite for consumer hardware and health-tech plays.